Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ABB Ltd | ABJA | Nov 22, 2024 | 53.00 | -0.93 |
Abbott Laboratories | ABL | Nov 22, 2024 | 112.24 | +2.33 |
AbbVie Inc. | 4AB | Nov 22, 2024 | 170.72 | +4.02 |
ABC | EK7 | Nov 22, 2024 | 0.41 | -1.74 |
ABC Arbitrage | 9BA | Nov 22, 2024 | 4.71 | -0.63 |
ABC-Mart Inc. | 5B8 | Nov 22, 2024 | 18.30 | +1.11 |
AbCellera Biologics Inc. - | 8QQ | Nov 22, 2024 | 2.61 | +4.16 |
Abcourt Mines, Inc. | AML | Nov 22, 2024 | 0.03 | +1.96 |
ABEN MINERALS LTD | R26 | Nov 22, 2024 | 0.03 | +5.08 |
Abercrombie & Fitch Company | AFT | Nov 22, 2024 | 142.78 | +7.43 |
Aberdeen Asia-Pacific Income Fund Inc | 9J9 | Nov 22, 2024 | 2.40 | 0.00 |
Aberdeen Asia-Pacificome Fund | 9J90 | Nov 22, 2024 | 14.46 | 0.00 |
Aberdeen International Inc | A8H | Nov 22, 2024 | 0.05 | +84.91 |
Aberdeen Standard European Logistics Income Plc | 5JX | Nov 22, 2024 | 0.69 | 0.00 |
Aberforth Smaller Companies Trust PLC | 0KJ | Nov 22, 2024 | 17.10 | +0.59 |
ABG Sundal Collier Holding | DAB | Nov 22, 2024 | 0.60 | +6.79 |
Abionyx Pharma | 609 | Nov 22, 2024 | 1.18 | -3.45 |
Abitare In Spa | 1BN | Nov 22, 2024 | 4.13 | -0.24 |
ABITIBI METALS CORP. | FW0 | Nov 22, 2024 | 0.23 | -2.53 |
Abivax | 2X1 | Nov 22, 2024 | 8.08 | -1.82 |
ABIVAX SA SP.ADR EO -,01 | 2X10 | Nov 22, 2024 | 7.75 | -4.32 |
ABL Group ASA | 26Q | Nov 22, 2024 | 0.77 | +0.52 |
Abliva | NTP | Nov 22, 2024 | 0.00 | +14.29 |
ABM Industries Incorporated | AB4 | Nov 22, 2024 | 54.50 | +1.87 |
ABM INVESTAMA TBK RP 100 | 0A1 | 0.00 | 0.00 | |
ABN AMRO Bank N.V. | AB2 | Nov 22, 2024 | 14.60 | -0.55 |
ABN AMRO BK.UNSP.ADR/1 | AB2A | Nov 22, 2024 | 14.50 | 0.00 |
ABO Wind AG | AB9 | Nov 22, 2024 | 38.00 | 0.00 |
ABO-Group | 3T61 | Nov 22, 2024 | 5.05 | 0.00 |
ABOUT YOU HOLDING AG | YOU | Nov 22, 2024 | 3.21 | +0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.